Ascorbic acid 6-palmitate modulates microglia M1/M2 polarization in lipopolysaccharide-stimulated BV-2 cells via

Qian Li1,2,3, Yao Wu2,3, Xue-Shen Chen2,3

  • 1Grade 2018, West China School of Basic Medical Sciences and Forensic Medicine, Sichuan University, Sichuan, 610041, Chengdu, PR China.

Abstract

Insights

Ascorbic acid 6-palmitate (L-AP) rebalances microglia polarization in neuroinflammation by targeting endoplasmic reticulum (ER) stress. L-AP modulates the PERK/elF2α pathway, offering a potential therapeutic strategy for CNS diseases.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Immunology

Background:

  • Microglia polarization is critical in central nervous system (CNS) diseases.
  • Endoplasmic reticulum (ER) stress exacerbates neuroinflammation and microglia polarization.
  • Ascorbic acid 6-palmitate (L-AP) is a dietary antioxidant with unclear anti-inflammatory mechanisms.

Purpose of the Study:

  • To investigate the effects of L-AP on lipopolysaccharide (LPS)-induced neuroinflammation in BV-2 cells.
  • To elucidate the underlying mechanisms of L-AP's anti-inflammatory actions, focusing on ER stress and microglia polarization.

Main Methods:

  • Utilized immortalized murine microglia BV-2 cells to assess L-AP's impact on microglia M1/M2 polarization.
  • Employed quantitative real-time PCR (qRT-PCR) and Western blotting to analyze molecular mechanisms.
  • Performed molecular docking to predict L-AP binding with protein kinase R-like ER kinase (PERK).

Main Results:

  • L-AP (62.5 µM) significantly modulated LPS-induced microglia M1/M2 polarization, increasing IL-10 and Arg-1.
  • L-AP down-regulated ER stress markers (GRP78, CHOP) in both LPS and tunicamycin (TM)-induced models.
  • L-AP inhibited LPS-induced PERK/eukaryotic initiation factor 2α (elF2α) activation, suggesting a direct interaction with PERK.

Conclusions:

  • L-AP effectively reconstructs microglia M1/M2 polarization balance in LPS-stimulated BV-2 cells.
  • The mechanism involves modulating the PERK/elF2α-mediated ER stress pathway.
  • L-AP demonstrates potential as a therapeutic agent for neuroinflammatory conditions.